Citations

Clear

80 citation(s) found for "Pignolo, RJ".

Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review
Scott, Christiaan, Mukaddam, Mona Al, Davis, Michelle, Cunto, Carmen L. De, Hsiao, Edward C. , Pignolo, Robert J., Schwegler, Odette , Artyomenko, Alexander, Croskery, Kim, Hanman, Kate, Sanchot, Boris, Warnants, Emma , Kaplan, Frederick S., Scott, Christiaan , Hsiao, Edward C , Scott, Christiaan, Mukaddam, Mona Al, Davis, Michelle, Cunto, Carmen L. De, Pignolo, Robert J., Schwegler, Odette , Artyomenko, Alexander, Croskery, Kim, Hanman, Kate, Sanchot, Boris, Warnants, Emma , Kaplan, Frederick S.

Mayo Clinic

Therapeutic Advances in Musculoskeletal Disease | December 18, 2025 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/1759720x251407060 | PMID 41427122 Get It

Background: Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare, disabling, genetic disorder characterized by progressive heterotopic ossification (HO). FOP care pathways are complex, and there are many underrepresented patients globally. Objectives: This scoping review aimed to identify global FOP case reports and investigate real-world management practices. Evidence sources, eligibility criteria, and charting methods: International/local databases and congress proceedings were searched. Publications reporting patient-level data for ⩾1 patient with an FOP primary diagnosis, published January 2000–January 2024, were eligible. Publication details, patient demographics, disease presentation, and care pathway were extracted. Data were charted through categorization of themes and frequency analyses. Results: Of 6064 publications screened, 369 were eligible, reporting on 541 patients with FOP. Most publications (82.4% (304/369)) reported an individual case; the remaining reported 2–25 cases. Cases were from 57 countries, most commonly in the Asia/Pacific region (47.0% (254/541)). Most patients had reportedly seen a single specialist (64.8% (59/91)), and care from multidisciplinary teams was reported for only 5.5% (5/91). HO (84.7% (458/541)) and great toe malformations (66.7% (361/541)) were the most commonly reported signs, though mobility limitations (46.2% (96/208)) and growths/lesions (38.5% (80/208)) were most common before diagnosis. The predominant drug classes reported for FOP treatment were corticosteroids (52.6% (102/194)) and nonsteroidal anti-inflammatory drugs (39.7% (77/194)). Surgeries were reported in 35.1% (190/541) of patients. Where specified, the most common surgery types were malformation correction/bone resection (43.6% (78/179)) and biopsies (34.1% (61/179)). Conclusion: This scoping review synthesized valuable real-world insights from case reports of FOP, potentially supporting outreach initiatives in underserved regions and facilitating shared learnings on diagnosis and treatment. Although the inherent selection bias of case studies toward atypical cases limits definitive conclusions, some global trends in the clinical management practices were revealed.
Same question, different solution: creating interest in geriatrics fellowship training and geriatrics
Magnabosco, L., Chen, Christina , Tung, Ericka E. , Garza, Maria Mendoza de la , Verdoorn, Brandon P. , Westmoreland, Glenda R., Pignolo, Robert J. , Magnabosco, Lara, Tung, Ericka, Verdoorn, Brandon, Pignolo, Robert

Mayo Clinic

Gerontology & Geriatrics Education | November 20, 2025 | Volume: 47 | Issue: 3 | Pages: 378-389

10.1080/02701960.2025.2565724 | PMID 41264294 Get It

Medical guidelines for fibrodysplasia ossificans progressiva
Kaplan, Frederick S. , Mukaddam, Mona Al , Hidalgo‐Bravo, Alberto , Brown, Matthew A. , Cali, Amanda, Crowe, C. R., Cunto, Carmen L. De, Delai, Patricia , Diecidue, Robert J. , Friedman, Clive, Grunwald, Zvi, Haga, Nobuhiko , Kitterman, Joseph A., Levy, Charles E. , Morhart, Rolf, Netelenbos, J.C., Shore, Eileen M. , Zasloff, Michael , Pignolo, Robert J. , Al Mukaddam, Mona , Hidalgo Bravo, Alberto , Brown, Matthew , Friedlander, Lisa , Hsiao, Edward C , Shore, Eileen M , Pignolo, Robert J , Kaplan, Frederick S , Baujat, Geneviève , Cho, Tae‐Joon , Crowe, Corrie, Cunto, Carmen De , Eekhoff, Elisabeth M. W. , Hsiao, Edward C. , Keen, Richard , Madhuri, Vrisha , Scott, Christiaan , Zhang, Ke‐Qin

Mayo Clinic

JBMR Plus | September 11, 2025 | Volume: 9 | Issue: 11 | Pages: No page available

10.1093/jbmrpl/ziaf150 | PMID 41143155 Get It

Abstract Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic condition characterized by congenital malformations of the great toes and progressive heterotopic ossification (HO) in specific anatomic patterns. Present management summarized here is focused on early diagnosis, assiduous avoidance of injury and iatrogenic harm, symptomatic amelioration of painful flare-ups, and optimization of residual function. Twenty-one members of the International Clinical Council on FOP (ICC) and seven consultants from 15 countries, chosen for their clinical expertise in FOP, developed this summary statement. Further advances in therapeutics will be based on rigorous clinical trials to assess novel and emerging treatment and prevention strategies. A detailed and updated exploration of the topics outlined in this brief perspective can be found in “The Medical Management of Fibrodysplasia Ossificans Progressiva: Current Treatment Considerations” which can be found on the International Clinical Council on FOP (ICC) website (www.iccfop.org).
Ectopic pseudojoints in fibrodysplasia ossificans progressiva
Pignolo, Robert J. , Mukaddam, Mona Al , Morhart, Rolf, Drake, Luke T, Kneeland, Bruce , Towler, O. Will , Al Mukaddam, Mona , Broski, Stephen, Broski, Stephen M. , Kaplan, Frederick S.

Mayo Clinic

JBMR Plus | June 27, 2025 | Volume: 9 | Issue: 8 | Pages: No page available

10.1093/jbmrpl/ziaf107 | PMID 40757145 Get It

Abstract Pseudoarthroses (false joints) occur as a complication of fracture healing in the normotopic skeleton but have not been reported at ectopic sites. Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic disorder characterized by progressive heterotopic ossification (HO) and congenital skeletal abnormalities including developmental arthropathy in the normotopic skeleton. Here, we report ectopic pseudojoint formation in 6 patients with FOP, all occurring after painful flare-ups and HO in soft connective tissues of the knee, hip, and forearm. To our knowledge, FOP is the only human condition in which ectopic pseudojoint formation occurs. These findings support that dysregulated BMP pathway signaling from mutant ACVR1 mediates not only HO, but also ectopic pseudojoint formation, and that ectopic pseudojoints can arise from de novo musculoskeletal elements.
Thoracic Deformity in Fibrodysplasia Ossificans Progressiva
Kaplan, Frederick S. , Sponseller, Paul D. , Pignolo, Robert J. , Sponseller, Paul D , Kaplan, Frederick S

Mayo Clinic

JBJS Reviews | May 22, 2025 | Volume: 13 | Issue: 5 | Pages: No page available

10.2106/jbjs.rvw.25.00042 | PMID 40403126 Get It

» Fibrodysplasia ossificans progressiva (FOP), the most severe form of heterotopic ossification (HO) in humans, may lead to severe thoracic deformity (TD) and thoracic insufficiency syndrome (TIS), the most common cause of mortality in individuals with FOP. » In this study, we examine the multiple causes of TD in FOP and propose a dynamic model for the development and evolution of TD that can be used to guide clinical care. This model posits that multiple factors, all originating from the causative gain-of-function mutation in activin receptor A, type 1, lead to TD in FOP. » Factors that lead to TD in FOP include early developmental costovertebral and facet joint arthropathy and joint ankylosis, progressive episodic flare-ups (both trauma induced or spontaneous) and subsequent HO, dysregulated soft tissue sensitivity to mechanical stimuli, growth plate dysregulation, and congenital rib fusions. These factors contribute to TD in FOP through a combination of intra-articular and extra-articular mechanisms, all amplified by growth. » Although FOP is a rare condition, it is illustrative of how a mutation in a critical receptor in the bone morphogenetic protein signaling pathway can cause a litany of musculoskeletal dysfunction that can lead to life-threatening consequences. Clinicians caring for individuals who have FOP must be aware of the occurrence, evolution, and implications of progressive TD and resultant TIS so that appropriate preventive measures such as avoidance of pulmonary infections, incentive spirometry, and diaphragmatic strengthening can be instituted.
Building an Interdisciplinary Workforce in Geroscience: Aligning Perspectives and Educational Goals
Al‐Naggar, Iman M. , Quinn, Crystal G, LaHue, Sara C. , Ocañas, Sarah R. , Yousefzadeh, Matthew J. , Kozikowski, Chester, McAbee‐Sevick, Heather, Curran, Sean P. , Justice, Jamie N. , Orr, Miranda E. , Thatcher, Christine, Espinoza, Sara , Newman, John C. , Pignolo, Robert J. , Yousefzadeh, Matthew J , Curran, Sean P , Justice, Jamie N , Newman, John C , Espinoza, Sara , Quinn, Crystal G, Campellone, Kenneth G. , Kuchel, George A.

Mayo Clinic

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences | April 24, 2025 | Volume: 80 | Issue: 9 | Pages: No page available

10.1093/gerona/glaf090 | PMID 40850699 Get It

Abstract The National Institute on Aging-funded Geroscience Education and Training Network held the “Building an Interdisciplinary Workforce in Geroscience: Aligning Perspectives and Educational Goals” preconference workshop at the 2023 Gerontological Society of America’s Annual Meeting. Parties involved in geroscience education and interested stakeholders addressed the development of didactic educational materials, training, and career development opportunities to equip learners with the skills to meet the demands of the emerging field of geroscience, from research to clinic and industry. Recent successes were presented, existing opportunities, gaps, and challenges identified and discussed, and solutions and future directions described.
Aging and Bone Metabolism
Pignolo, Robert J.

Mayo Clinic

Comprehensive Physiology | April 2, 2025 | Volume: 13 | Issue: 1 | Pages: 4355-4386

10.1002/j.2040-4603.2023.tb00253.x Get It

Abstract Changes in bone architecture and metabolism with aging increase the likelihood of osteoporosis and fracture. Age‐onset osteoporosis is multifactorial, with contributory extrinsic and intrinsic factors including certain medical problems, specific prescription drugs, estrogen loss, secondary hyperparathyroidism, microenvironmental and cellular alterations in bone tissue, and mechanical unloading or immobilization. At the histological level, there are changes in trabecular and cortical bone as well as marrow cellularity, lineage switching of mesenchymal stem cells to an adipogenic fate, inadequate transduction of signals during skeletal loading, and predisposition toward senescent cell accumulation with production of a senescence‐associated secretory phenotype. Cumulatively, these changes result in bone remodeling abnormalities that over time cause net bone loss typically seen in older adults. Age‐related osteoporosis is a geriatric syndrome due to the multiple etiologies that converge upon the skeleton to produce the ultimate phenotypic changes that manifest as bone fragility. Bone tissue is dynamic but with tendencies toward poor osteoblastic bone formation and relative osteoclastic bone resorption with aging. Interactions with other aging physiologic systems, such as muscle, may also confer detrimental effects on the aging skeleton. Conversely, individuals who maintain their BMD experience a lower risk of fractures, disability, and mortality, suggesting that this phenotype may be a marker of successful aging. © 2023 American Physiological Society. Compr Physiol 13:4355‐4386, 2023.
Decentralized subject recruitment for a prospective community surveillance system: The influence of social determinants of health on inclusion of minorities in research
Wi, Chung I., Pignolo, Robert J. , Bosch, Wendelyn , King, Katherine C. , Ryu, Euijung , Natoli, Traci L., Ihrke, Kathy, Spiten, Matthew J., Speiser, Lisa , Juhn, Young J. , Pignolo, Robert, Natoli, Traci, Spiten, Matthew, Juhn, Y J , Takahashi, Paul Y. , Wi, Chung‐Il , King, Katherine, Hidaka, Brandon H.

Mayo Clinic

Journal of Clinical and Translational Science | March 27, 2025 | Volume: 9 | Issue: 1 | Pages: No page available

10.1017/cts.2025.18 | PMID 40416804 Get It

Abstract Background/Objective: Decentralized research has many advantages; however, little is known about the representativeness of a source population in decentralized studies. We recruited participants aged 18-64 years from four states from June to December 2022 for a prospective cohort study to assess viral epidemiology. Our aim was to determine the association between age, gender, race/ethnicity, rurality, and socioeconomic status (SES) on study participation in a decentralized prospective cohort study. Methods: We consented 9,286 participants from 231,099 (4.0%) adults with the mean age of 45.6 years (±12.0). We used an electronic decentralized approach for recruitment. Consented participants were more likely to be non-Hispanic White, female, older, urban residents, have more health conditions, and possessed higher socioeconomic status (SES) compared to those non-consented. Results: We observed an interaction between SES and race-ethnicity on the odds of consent (P = 0.006). Specifically, SES did not affect non-Hispanic white participation rates(OR 1.24 95% CI 1.16 – 1.32] for the highest SES quartile compared to those with the lowest SES quartile) as much as it did participants combined across the other races (OR 1.73; 95% CI 1.45 – 2.98]) Conclusion: The relationship between SES and consent rates might be disproportionately greater in historically disadvantaged groups, compared to non-Hispanic White. It suggests that instead of focusing on enrollment of specific minority groups in research, there is value in future research exploring and addressing the diversity of barriers to trials within minority groups. Our study highlights that decentralized studies need to address social determinants of health, especially in under-resourced populations.
Effects of Age and Muscle Activation on Three-Dimensional Spine Kinematics and Asymmetry in Elderly Adults
Rezaei, Asghar , Cheng, Chih-Hsiu , Pignolo, Robert J. , Lu, Lichun , Kaufman, Kenton R. , Kaufman, Kenton R

Mayo Clinic

Journal of Clinical Medicine | February 27, 2025 | Volume: 14 | Issue: 5 | Pages: 1610

10.3390/jcm14051610 | PMID 40095565 Get It

Background/Objectives: Limited spinal range of motion (ROM) is linked to low back disorders, emphasizing the need to maintain mobility in the elderly. This study measured maximum spinal ROM, asymmetrical patterns, and the effects of age and muscle activation on spinal mobility. Methods: Forty healthy participants aged 50 and older were recruited. An optical motion capture system recorded three-dimensional coordinates of reflective markers placed on spinal landmarks. Asymmetry was analyzed in sidebending and axial rotation. Electromyography (EMG) data were collected bilaterally from paraspinal muscles at L3 during flexion, extension, sidebending, and axial rotation. Results: Trunk ROM averaged 111° in flexion, 38° in extension, 46° in sidebending, and 87° in axial rotation. Kinematic asymmetry was observed in sidebending and axial rotation. ROM decreased with age in flexion motion (p ≤ 0.04). EMG activity was significantly correlated with ROM data for all combined motions (p = 0.0002). The strongest EMG signal was recorded during flexion, whereas the weakest signal was observed during extension. EMG activity also correlated with kinematic asymmetry (p ≤ 0.03). Conclusions: Age and muscle activation significantly influence spinal ROM in the elderly. Lumbar kinematic asymmetry can be partially attributed to paraspinal muscle activation, underscoring the importance of analyzing asymmetrical motions in conjunction with EMG activity.
FOP: From Biomolecules to Hope
Kaplan, Frederick S. , Pignolo, Robert J. , Kaplan, Frederick S

Mayo Clinic

Biomolecules | February 24, 2025 | Volume: 15 | Issue: 3 | Pages: 328

10.3390/biom15030328 | PMID 40149864 Get It

In the introduction to his 1970 textbook BIOCHEMISTRY, Albert Lehninger wrote “Living things are composed of lifeless molecules [...]